US
Ugur Sahin
Chief Executive Officer10% Owner

Ugur Sahin insider trades: BioNTech (BNTX) stock sales

Chief Executive Officer, BioNTech Last trade Oct 9, 2026 13 Form 4 filings
$77.0M
Sold, last 12 months
13 sales
$0
Bought, last 12 months
0 buys
13
Open-market trades
since 2026
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Ugur reports to the SEC

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
Oct 9, 2026BNTX↓ Sell$5.9M
Oct 7, 2026BNTX↓ Sell$2.3M
Oct 6, 2026BNTX↓ Sell$9.0M
Oct 2, 2026BNTX↓ Sell$3.3M
Sep 30, 2026BNTX↓ Sell$6.5M
Sep 28, 2026BNTX↓ Sell$6.0M
Sep 24, 2026BNTX↓ Sell$6.8M
Sep 22, 2026BNTX↓ Sell$7.9M
Sep 18, 2026BNTX↓ Sell$6.2M
Sep 16, 2026BNTX↓ Sell$4.7M
Sep 14, 2026BNTX↓ Sell$8.4M
Sep 10, 2026BNTX↓ Sell$2.0M
Sep 4, 2026BNTX↓ Sell$7.9M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other BNTX insiders

Open-market trades in the last 12 months

About Ugur Sahin's insider trades

Ugur Sahin is Chief Executive Officer at BioNTech (BNTX). Since Sep 4, 2026, Ugur has reported no open-market purchases and 13 sales worth $77.0M on SEC Form 4. In the last 12 months: 13 sales ($77.0M).

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BNTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.